← FDA Drug Approvals (Drugs@FDA)

LANREOTIDE ACETATE

NDA · New Drug Application · Sponsor: INVAGEN PHARMS · Approved 2021-12-17

Drug application

FDA Application #

NDA215395

Application type

New Drug Application

Brand name

LANREOTIDE ACETATE

Generic name

LANREOTIDE ACETATE

Active ingredients

LANREOTIDE ACETATE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

INVAGEN PHARMS

Manufacturer

Cipla USA Inc.

First approval

2021-12-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown